RGCB Director Radhakrishna Pillai Retired on Aug 31

  THIRUVANANTHAPURAM: Professor M Radhakrishna Pillai, whose trailblazing initiatives propelled Rajiv Gandhi Centre for Biotechnology.

COVID-19: RGCB Products for Pandemic Management Get Manufacturing License

THIRUVANANTHAPURAM: A cost-effective Rapid Antibody Card, developed indigenously by Government of India’s Rajiv Gandhi Centre.

Pankajakasthuri Promising Interim Results for ZingiVir–H Among COVID-19 Patients

THIRUVANANTHAPURAM: Pankajakasthuri Herbals India Private Limited (PKHIL) today announced promising interim clinical trial results for.

Life After Pulling Through Cancer is Much More Meaningful: Mamta Mohandas

  THIRUVANANTHAPURAM: “I think my love for life has increased one hundred times more because.

Need to Commercialize Outcomes of Academic Research

THIRUVANANTHAPURAM: Despite significant scientific and technological research being carried out by India’s excellent academic institutions,.

Early Detection Vital in Tackling Cancer: Experts

THIRUVANANTHAPURAM: Early detection and providing basic treatment are crucial in managing cancer, especially in countries.

Incidence of Cancer to Double by 2040: WHO Official

THIRUVANANTHAPURAM: Noting that the incidence of cancer is expected to double by 2040, a top.

RGCB to Host Cancer Research Association Annual Meet

THIRUVANANTHAPURAM: Showcasing the path-breaking developments in cancer research in the country, Rajiv Gandhi Centre for.

Rajiv Gandhi Centre for Biotechnology Launches Maiden MSc Courses

THIRUVANANTHAPURAM: Rajiv Gandhi Centre for Biotechnology (RGCB), a National institute under the Department of Biotechnology,.

India Edition of ASCODD concludes; Witnesses Participation of More Young Investigators

KOCHI: The 14th edition of Asian Conference on Diarrhoeal Diseases and Nutrition (ASCODD) concluded on.